Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

The Lanceolate hair-J mutation in mice mimics human hair disorders like Netherton's syndrome.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Lysophosphatidic acid boosts stem cell growth and movement by creating reactive oxygen species.

Overexpression of IKZF1 and Ikaros causes hair loss in mice similar to alopecia areata.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

A new type of nerve cell involved in itch perception was discovered.

NLRP3 helps control inflammation and repair in wound healing, making it a potential target for treatment.

The research found that a protein called caveolin-1 is reduced in psoriasis, but reintroducing it can help alleviate some psoriasis symptoms.

Mutations in the FOXN1 gene cause severe immune issues but don't affect hair and nails.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Overexpression of ΔNLef1 in mouse skin leads to hair loss, cysts, and skin tumors.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Hair follicles help attract immune cells to minor skin injuries.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Lgr5 and the vitamin D receptor are key in controlling skin inflammation and tumor risk in mice.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

The Foxn1(-/-) nude mouse shows disrupted and expanded skin stem cell areas due to high Lhx2 levels.

Mice with too much sPLA₂-IIA have hair loss and poor wound healing due to abnormal hair growth and stem cell depletion.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Dupilumab can both heal and cause hair loss.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Too much IKZF1 and Ikaros protein may cause alopecia areata.